Literature DB >> 23689714

Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.

Lara M de Almeida, Maria Rita E de Araújo, Andrey G Sacramento, Mónica Pavez, Alinne G de Souza, Fernanda Rodrigues, Ana C Gales, Nilton Lincopan, Jorge L M Sampaio, Elsa M Mamizuka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689714      PMCID: PMC3719711          DOI: 10.1128/AAC.00437-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

Review 1.  Resistance to linezolid caused by modifications at its binding site on the ribosome.

Authors:  Katherine S Long; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Clonal dissemination of linezolid-resistant Staphylococcus haemolyticus exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary care hospital in Brazil.

Authors:  Lara M de Almeida; Nilton Lincopan; Maria Rita E de Araújo; Elsa M Mamizuka
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

3.  Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.

Authors:  Klaudia Kosowska-Shick; Kathleen G Julian; Pamela L McGhee; Peter C Appelbaum; Cynthia J Whitener
Journal:  Diagn Microbiol Infect Dis       Date:  2010-09       Impact factor: 2.803

4.  Rapid and accurate identification of human-associated staphylococci by use of multiplex PCR.

Authors:  Shintaro Hirotaki; Takashi Sasaki; Kyoko Kuwahara-Arai; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

5.  Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.

Authors:  Andrea Endimiani; Martha Blackford; Elliot C Dasenbrook; Michael D Reed; Saralee Bajaksouszian; Andrea M Hujer; Susan D Rudin; Kristine M Hujer; Vincent Perreten; Louis B Rice; Michael R Jacobs; Michael W Konstan; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

  5 in total
  5 in total

1.  Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.

Authors:  Rasmus N Klitgaard; Eleni Ntokou; Katrine Nørgaard; Daniel Biltoft; Lykke H Hansen; Nicolai M Trædholm; Jacob Kongsted; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.

Authors:  Lara M de Almeida; Maria Rita E de Araújo; Marta F Iwasaki; Andrey G Sacramento; Darlan Rocha; Leila P da Silva; Mónica Pavez; Artemir C de Brito; Laís Carolina S Ito; Ana C Gales; Nilton Lincopan; Jorge L M Sampaio; Elsa M Mamizuka
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

3.  Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.

Authors:  Yueru Tian; Tianming Li; Yuanjun Zhu; Bei Wang; Xue Zou; Min Li
Journal:  BMC Microbiol       Date:  2014-11-25       Impact factor: 3.605

4.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

5.  Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.

Authors:  Soraya Mendoza-Olazarán; Rayo Morfín-Otero; Licet Villarreal-Treviño; Eduardo Rodríguez-Noriega; Jorge Llaca-Díaz; Adrián Camacho-Ortiz; Gloria M González; Néstor Casillas-Vega; Elvira Garza-González
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.